Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gemfibrozil - Forest Hills Lab

Next Previous
Drug Profile

Gemfibrozil - Forest Hills Lab

Alternative Names: FHL-301

Latest Information Update: 03 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Forest Hills Lab
  • Class Anti-inflammatories; Antihyperlipidaemics; Antiparkinsonians; Ethers; Fibric acid derivatives; Pentanoic acids; Phenyl ethers; Small molecules; Xylenes
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Parkinson's disease

Most Recent Events

  • 19 Aug 2026 Forest Hills Lab withdraws phase-II clinical trials in Parkinson's disease in USA (PO) prior to enrolment (NCT05931484)
  • 17 Jan 2024 Phase-II clinical trials in Parkinson's disease in USA (PO) prior to January 2024 (Forest Hills Lab pipeline, January 2024)
  • 10 Jul 2023 Preclinical trials in Parkinson's disease in China (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top